Open Forum

Pros and cons of splenectomy in patients with myelofibrosis undergoing stem cell transplantation

• Z Li
• HJ Deeg

p53 alterations in human leukemia–lymphoma cell lines: in vitroartifact or prerequisite for cell immortalization?

• HG Drexler
• S Fombonne
• CC Uphoff

Detection of MUM1/IRF4-IgH fusion in multiple myeloma

• S Yoshida
• N Nakazawa
• R Ueda

TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells

• Y Gazitt

Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia

• MW Lensch
• RK Rathbun
• GC Bagby Jr

The Tel-PDGFRβ fusion gene produces a chronic myeloproliferative syndrome in transgenic mice

• KA Ritchie
• AAG Aprikyan
• DD Hickstein

Frequent allelic imbalance but infrequent microsatellite instability in gastric lymphoma

• MA Hoeve
• SC Ferreira Mota
• JHJM van Krieken

False human hematopoietic cell lines: cross-contaminations and misinterpretations

• HG Drexler
• WG Dirks
• RAF MacLeod

Guidelines for the characterization and publication of human malignant hematopoietic cell lines

• HG Drexler
• Y Matsuo

Examination of a role for idiotypy in the disease remission of a long-term survivor of adult T cell leukemia treated with anti-Tac antibody

• GA Kingsbury
• TA Waldmann
• RP Junghans

Chronic myelogenous leukemia: too much or too little growth, or both?

• CM Verfaillie

t(14;18), a journey to eternity

• JPP Meijerink

Determination of clonality in patients who present with diagnostic dilemmas: a laboratory experience and review of the literature

• SP Rockman

True histiocytic lymphoma: is it an entity?

• M Tarek Elghetany